Search Results 1161-1170 of 15545 for fecal microbiota transplant

  1. Carl H. Cramer, II, M.D. - Doctors and Medical Staff - Mayo Clinic

    His primary clinical interests include pediatric nephrology, transplant in infants, and transplant in patients with urinary tract anomalies. Dr. Cramer leads a ...

  2. A Study to Explore Quality of Life According to Treatment Plan for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

    A Study to Explore Quality of Life According to Treatment Plan for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant · Share · Facebook ...

  3. A Study Using Chemotherapy to Treat Patients with Myelodysplastic Syndrome Before Donor Stem Cell Transplant - Mayo Clinic

    Giving chemotherapy before a donor stem cell transplant helps stop the growth of cancer cells in the bone marrow, including normal blood-forming cells (stem ...

  4. Functional Bowel Disorders Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine the effect of NGM282 on colonic transit, bile acid homeostasis, and fecal fat in subjects with functional constipation ...

  5. Digestive Diseases Clinical Trials - Medical Professionals

    Mucosal and Microbiota Changes During Acute Campylobacteriosis. Rochester ... The purpose of this study is to collect blood and stool samples to validate and ...

  6. Micafungin (intravenous route) - Mayo Clinic

    This medicine is also used to prevent candida infections in patients who have a weakened immune system (eg, hematopoietic stem cell transplant). It is also ...

  7. Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured from Deceased Donors with High Kidney Donor Profile Index (KDPI) - Mayo Clinic

    Participation eligibility · Male or female kidney transplant candidates age 18 and above. · Patient is receiving kidney allograft from deceased donor with KDPI > ...

  8. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant. Print details.

  9. Publications - Musab S. Hommos, M.B.B.S. - Mayo Clinic

    Hommos MS, Brown A, Trollinger B, Sekkarie M, Alasfar S. Do not forget about transplant patients during disasters. Curr Opin Nephrol Hypertens.

  10. Publications - Raj Satyanarayana, M.D. - Mayo Clinic

    Improving graft survival for patients undergoing liver transplantation. Clin Transplant. 2011 May-Jun; 25(3):E345-55. Epub 2011 Mar 23. View PubMed; Begum R ...